Self-Control Improvement Intervention (SCII): Improving Abstinence in Smokers. More than 15 years of our translational research has shown that discounting (i.e., devaluing) future rewards in favor of immediate rewards (which we will refer to as self-control failure) is endemic among individuals addicted to cigarettes and other drugs. Indeed, we propose that individuals who excessively discount future rewards may be stimulus bound and more susceptible to drug-related cues and negative consequences. Consistent with this view, treatment success among smokers is inversely correlated with their rates of discounting. Unfortunately, no research translating basic findings on excessive discounting among smokers into clinical treatments has been conducted. This proposed project is a systematic effort to translate basic research on self-control failure into effective interventons to normalize or improve self-control among smokers. In the first phase, a laboratory study will determine if smokers with less self-control are more stimulus bound. Within this phase, we will delineate the target for subsequent intervention, self-control failure (i.e., excessive discounting, and its functional relation to measures that could determine whether smokers are stimulus bound under cigarette available and deprivation conditions. Concurrently, we will examine the quantitative relation between smokers' discounting rates and responsiveness to those measures. In the second phase, we will conduct a proof-of-concept field study testing a novel Self-Control Improvement Intervention (SCII). This intervention is based on our prior work demonstrating that working memory training (hereafter, SCII) improves self-control in stimulant-dependent individuals. We will examine (1) whether SCII decreases the extent to which smokers are stimulus bound, and (2) if this decrease in being stimulus bound is dependent on baseline self- control level. In the third phase, we will seek to improve current smoking cessation treatments (i.e., combination cognitive behavioral therapy and nicotine replacement therapy) that have been shown to be efficacious, but still fail to produce abstinence in the vast majority o participants. This will be accomplished by incorporating SCII into the multi-modal smoking treatment program among those individuals who we demonstrated to be sensitive to the SCII in Phase 2.

Public Health Relevance

Despite smoking being the single largest preventable cause of mortality and morbidity in the U.S., even the most efficacious smoking cessation treatments fail to produce abstinence among the majority of smokers. As self-control failure is a major source of poor treatment outcomes among smokers, a greater understanding of self-control failure and its repair could lead to new and more refined approaches to smoking cessation treatment. We will attempt to improve treatment outcomes in three inter-related Aims: (1) a basic research study to characterize, in detail, self-control failure among smokers and its relationship to measures that suggest smokers are more sensitive to the immediate environment (stimulus bound), (2) a proof-of-concept study to characterize a novel Self-Control Improvement Intervention (SCII) on measures indicative of being stimulus bound among smokers, and (3) a pilot/feasibility study to address the role of our SCII in a multi-modal smoking cessation treatment regimen.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA034755-03
Application #
8858605
Study Section
Risk, Prevention and Intervention for Addictions Study Section (RPIA)
Program Officer
Aklin, Will
Project Start
2013-07-15
Project End
2016-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
3
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Virginia Polytechnic Institute and State University
Department
Type
Organized Research Units
DUNS #
003137015
City
Blacksburg
State
VA
Country
United States
Zip Code
24060
Pope, Derek A; Poe, Lindsey; Stein, Jeffrey S et al. (2018) Past and future preference reversals are predicted by delay discounting in smokers and non-smokers. Exp Clin Psychopharmacol :
Bickel, Warren K; Mellis, Alexandra M; Snider, Sarah E et al. (2018) 21st century neurobehavioral theories of decision making in addiction: Review and evaluation. Pharmacol Biochem Behav 164:4-21
Hall, Peter A; Bickel, Warren K; Erickson, Kirk I et al. (2018) Neuroimaging, neuromodulation, and population health: the neuroscience of chronic disease prevention. Ann N Y Acad Sci 1428:240-256
Mellis, Alexandra M; Snider, Sarah E; Bickel, Warren K (2018) Narrative theory: II. Self-generated and experimenter-provided negative income shock narratives increase delay discounting. Exp Clin Psychopharmacol 26:113-118
Athamneh, Liqa N; Stein, Jeffrey S; Amlung, Michael et al. (2018) Validation of a brief behavioral economic assessment of demand among cigarette smokers. Exp Clin Psychopharmacol :
Kwako, Laura E; Bickel, Warren K; Goldman, David (2018) Addiction Biomarkers: Dimensional Approaches to Understanding Addiction. Trends Mol Med 24:121-128
Heckman, Bryan W; MacQueen, David A; Marquinez, Nicole S et al. (2017) Self-control depletion and nicotine deprivation as precipitants of smoking cessation failure: A human laboratory model. J Consult Clin Psychol 85:381-396
Mellis, Alexandra M; Woodford, Alina E; Stein, Jeffrey S et al. (2017) A second type of magnitude effect: Reinforcer magnitude differentiates delay discounting between substance users and controls. J Exp Anal Behav 107:151-160
Moody, Lara N; Poe, Lindsey M; Bickel, Warren K (2017) Toward a laboratory model for psychotherapeutic treatment screening: Implementation intentions and incentives for abstinence in an analog of smoking relapse. Exp Clin Psychopharmacol 25:373-379
Athamneh, Liqa N; Stein, Jeffrey S; Bickel, Warren K (2017) Will delay discounting predict intention to quit smoking? Exp Clin Psychopharmacol 25:273-280

Showing the most recent 10 out of 33 publications